In other words, when addressing cardiovascular diseases, it is important to not only focus on inhibiting the ACE/Ang II/AT1R axis but also consider activating the ACE2/Ang‐(1–7)/MasR axis. The gene discussed is ACE; the disease is cardiovascular disorder.